Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Douglas B. Evans MD

Douglas B. Evans MD

Chairman, Professor

Institution: Medical College of Wisconsin
Department: Surgery
Division: Administration
Program: General


Publications

  • Neoadjuvant chemotherapy for localized pancreatic cancer: too little or too long? (White RR, Evans DB) Ann Surg Oncol 2014 May;21(5):1508-9 PMID 24452411
  • Reply: To PMID 23816382. (Pilgrim CH, Evans DB, Christians KK) J Am Coll Surg 2014 Feb;218(2):307-8 PMID 24440074
  • Optimal Management of the Splenic Vein at the Time of Venous Resection for Pancreatic Cancer: Importance of the Inferior Mesenteric Vein. (Pilgrim CH, Tsai S, Tolat P, Patel P, Rilling W, Evans DB, Christians KK) J Gastrointest Surg 2013 Dec 18: PMID 24347313
  • Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival. (Tzeng CW, Tran Cao HS, Lee JE, Pisters PW, Varadhachary GR, Wolff RA, Abbruzzese JL, Crane CH, Evans DB, Wang H, Abbott DE, Vauthey JN, Aloia TA, Fleming JB, Katz MH) J Gastrointest Surg 2014 Jan;18(1):16-24; discussion 24-5 PMID 24241967
  • Cost analysis of thyroid lobectomy and intraoperative frozen section versus total thyroidectomy in patients with a cytologic diagnosis of "suspicious for papillary thyroid cancer". (Leiker AJ, Yen TW, Cheung K, Evans DB, Wang TS) Surgery 2013 Dec;154(6):1307-13; discussion 1313-4 PMID 24238049
  • Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer. (Tran Cao HS, Balachandran A, Wang H, Nogueras-González GM, Bailey CE, Lee JE, Pisters PW, Evans DB, Varadhachary G, Crane CH, Aloia TA, Vauthey JN, Fleming JB, Katz MH) J Gastrointest Surg 2014 Feb;18(2):269-78; discussion 278 PMID 24129826
  • The utility of routine preoperative cervical ultrasonography in patients undergoing thyroidectomy for differentiated thyroid cancer. (O'Connell K, Yen TW, Quiroz F, Evans DB, Wang TS) Surgery 2013 Oct;154(4):697-701; discussion 701-3 PMID 24011674
  • Pre-operative ultrasound identification of thyroiditis helps predict the need for thyroid hormone replacement after thyroid lobectomy. (Morris LF, Iupe IM, Edeiken-Monroe BS, Warneke CL, Hansen MO, Evans DB, Lee JE, Grubbs EG, Perrier ND) Endocr Pract 2013 Nov-Dec;19(6):1015-20 PMID 24013973
  • Borderline resectable/locally advanced pancreatic adenocarcinoma: improvements needed in population-based registries. (Miura JT, Evans DB, Pappas SG, Gamblin TC, Turaga KK) Ann Surg Oncol 2013 Dec;20(13):4338-47 PMID 24002538
  • Rational study endpoint(s) for preoperative trials in pancreatic cancer: pathologic response rate, margin negative resection, overall survival or 'all of the above'? (Varadhachary GR, Evans DB) Ann Surg Oncol 2013 Nov;20(12):3712-4 PMID 23943023
  • Mesocaval shunting: a novel technique to facilitate venous resection and reconstruction and enhance exposure of the superior mesenteric and celiac arteries during pancreaticoduodenectomy. (Pilgrim CH, Tsai S, Evans DB, Christians KK) J Am Coll Surg 2013 Sep;217(3):e17-20 PMID 23816382
  • Factors that influence parathyroid hormone half-life: determining if new intraoperative criteria are needed. (Leiker AJ, Yen TW, Eastwood DC, Doffek KM, Szabo A, Evans DB, Wang TS) JAMA Surg 2013 Jul;148(7):602-6 PMID 23677330
  • Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility or futility? (Pappas SG, Christians KK, Tolat PP, Mautz AP, Lal A, McElroy L, Gamblin TC, Turaga KK, Tsai S, Erickson B, Ritch P, Evans DB) HPB (Oxford) 2014 Jan;16(1):70-4 PMID 23496023
  • The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. (Abbott DE, Tzeng CW, Merkow RP, Cantor SB, Chang GJ, Katz MH, Bentrem DJ, Bilimoria KY, Crane CH, Varadhachary GR, Abbruzzese JL, Wolff RA, Lee JE, Evans DB, Fleming JB) Ann Surg Oncol 2013 Dec;20 Suppl 3:S500-8 PMID 23397153
  • Focused parathyroidectomy with intraoperative parathyroid hormone monitoring in patients with lithium-associated primary hyperparathyroidism. (Wade TJ, Yen TW, Amin AL, Evans DB, Wilson SD, Wang TS) Surgery 2013 May;153(5):718-22 PMID 23352236
  • Long-term outcomes of surgical treatment for hereditary pheochromocytoma. (Grubbs EG, Rich TA, Ng C, Bhosale PR, Jimenez C, Evans DB, Lee JE, Perrier ND) J Am Coll Surg 2013 Feb;216(2):280-9 PMID 23317575
  • Distal splenorenal and temporary mesocaval shunting at the time of pancreatectomy for cancer: initial experience from the Medical College of Wisconsin. (Christians KK, Riggle K, Keim R, Pappas S, Tsai S, Ritch P, Erickson B, Evans DB) Surgery 2013 Jul;154(1):123-31 PMID 23305596
  • Current staging systems for pancreatic cancer. (Appel BL, Tolat P, Evans DB, Tsai S) Cancer J 2012 Nov-Dec;18(6):539-49 PMID 23187840
  • Long-term follow-up data may help manage patient and parent expectations for pediatric patients undergoing thyroidectomy. (Morris LF, Waguespack SG, Warneke CL, Ryu H, Ying AK, Anderson BJ, Sturgis EM, Clayman GL, Lee JE, Evans DB, Grubbs EG, Perrier ND) Surgery 2012 Dec;152(6):1165-71 PMID 23158186
  • Predicting the need for calcium and calcitriol supplementation after total thyroidectomy: results of a prospective, randomized study. (Cayo AK, Yen TW, Misustin SM, Wall K, Wilson SD, Evans DB, Wang TS) Surgery 2012 Dec;152(6):1059-67 PMID 23068088
  • Is previous same quadrant surgery a contraindication to laparoscopic adrenalectomy? (Mazeh H, Froyshteter AB, Wang TS, Amin AL, Evans DB, Sippel RS, Chen H, Yen TW) Surgery 2012 Dec;152(6):1211-7 PMID 23068085
  • Novel multimodality treatment sequencing for extrahepatic (mid and distal) cholangiocarcinoma. (Turaga KK, Tsai S, Wiebe LA, Evans DB, Gamblin TC) Ann Surg Oncol 2013 Apr;20(4):1230-9 PMID 23064778
  • Effect of prophylactic central compartment neck dissection on serum thyroglobulin and recommendations for adjuvant radioactive iodine in patients with differentiated thyroid cancer. (Wang TS, Evans DB, Fareau GG, Carroll T, Yen TW) Ann Surg Oncol 2012 Dec;19(13):4217-22 PMID 23010732
  • Ultrasonography should not guide the timing of thyroidectomy in pediatric patients diagnosed with multiple endocrine neoplasia syndrome 2A through genetic screening. (Morris LF, Waguespack SG, Edeiken-Monroe BS, Lee JE, Rich TA, Ying AK, Warneke CL, Evans DB, Perrier ND, Grubbs EG) Ann Surg Oncol 2013 Jan;20(1):53-9 PMID 22890595
  • No need to abandon unilateral parathyroid surgery. (Hodin R, Angelos P, Carty S, Chen H, Clark O, Doherty G, Duh QY, Evans DB, Heller K, Inabnet W, Kebebew E, Pasieka J, Perrier N, Sturgeon C) J Am Coll Surg 2012 Aug;215(2):297; author reply 297-300 PMID 22818100
  • Critical steps for pancreaticoduodenectomy in the setting of pancreatic adenocarcinoma. (Christians KK, Tsai S, Tolat PP, Evans DB) J Surg Oncol 2013 Jan;107(1):33-8 PMID 22711619
  • Efficacy and safety of self-expandable metal stents for biliary decompression in patients receiving neoadjuvant therapy for pancreatic cancer: a prospective study. (Aadam AA, Evans DB, Khan A, Oh Y, Dua K) Gastrointest Endosc 2012 Jul;76(1):67-75 PMID 22483859
  • Outcomes and economic analysis of routine preoperative 4-dimensional CT for surgical intervention in de novo primary hyperparathyroidism: does clinical benefit justify the cost? (Abbott DE, Cantor SB, Grubbs EG, Santora R, Gomez HF, Evans DB, Lee JE, Vu T, Perrier ND) J Am Coll Surg 2012 Apr;214(4):629-37; discussion 637-9 PMID 22321526
  • Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. (Wang J, Estrella JS, Peng L, Rashid A, Varadhachary GR, Wang H, Lee JE, Pisters PW, Vauthey JN, Katz MH, Gomez HF, Evans DB, Abbruzzese JL, Fleming JB, Wang H) Cancer 2012 Aug 1;118(15):3801-11 PMID 22180096
  • Population-level predictors of persistent hyperparathyroidism. (Perrier ND, Evans DB) Surgery 2011 Dec;150(6):1120-1 PMID 22136830
  • Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are important. (Dickson PV, Rich TA, Xing Y, Cote GJ, Wang H, Perrier ND, Evans DB, Lee JE, Grubbs EG) Surgery 2011 Dec;150(6):1143-52 PMID 22136834
  • Papillary carcinoma of the thyroid: balancing principles of oncology with emerging technology. (Evans DB) Surgery 2011 Dec;150(6):1015-22 PMID 22136816
  • Nonlocalizing imaging studies for hyperparathyroidism: where to explore first? (Amin AL, Wang TS, Wade TJ, Quiroz FA, Hellman RS, Evans DB, Yen TW) J Am Coll Surg 2011 Dec;213(6):793-9 PMID 22014659
  • Primary hyperparathyroidism with a history of head and neck irradiation: the consequences of associated thyroid tumors. (Wilson SD, Doffek KM, Wang TS, Krzywda EA, Evans DB, Yen TW) Surgery 2011 Oct;150(4):869-77 PMID 22000202
  • Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytoma. (Dickson PV, Alex GC, Grubbs EG, Ayala-Ramirez M, Jimenez C, Evans DB, Lee JE, Perrier ND) Surgery 2011 Sep;150(3):452-8 PMID 21878230
  • Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation. (Estrella JS, Rashid A, Fleming JB, Katz MH, Lee JE, Wolf RA, Varadhachary GR, Pisters PW, Abdalla EK, Vauthey JN, Wang H, Gomez HF, Evans DB, Abbruzzese JL, Wang H) Cancer 2012 Jan 1;118(1):268-77 PMID 21735446
  • Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trial. (Katz MH, Wolff R, Crane CH, Varadhachary G, Javle M, Lin E, Evans DB, Lee JE, Fleming JB, Pisters PW) Ann Surg Oncol 2011 Dec;18(13):3615-22 PMID 21701927
  • ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. (Kim MP, Fleming JB, Wang H, Abbruzzese JL, Choi W, Kopetz S, McConkey DJ, Evans DB, Gallick GE) PLoS One 2011;6(6):e20636 PMID 21695188
  • Posterior retroperitoneoscopic adrenalectomy: a contemporary American experience. (Dickson PV, Jimenez C, Chisholm GB, Kennamer DL, Ng C, Grubbs EG, Evans DB, Lee JE, Perrier ND) J Am Coll Surg 2011 Apr;212(4):659-65; discussion 665-7 PMID 21463807
  • Adjuvant therapy for pancreatic cancer: a logical strategy in search of progress. (Evans DB, Wolff RA) Ann Surg Oncol 2011 May;18(5):1224-8 PMID 21384245
  • Erratum to: Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy. (Tamm EP, Loyer EM, Faria S, Raut CP, Evans DB, Wolff RA, Crane CH, Dubrow RA, Charnsangavej C) Abdom Imaging 2014 Feb;39(1):236 PMID 21350817
  • Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A? (Grubbs EG, Waguespack SG, Rich TA, Xing Y, Ying AK, Evans DB, Lee JE, Perrier ND) Surgery 2010 Dec;148(6):1302-9; discussion 1309-10 PMID 21134565
  • The importance of a multidisciplinary approach to endocrine tumors. (Wang TS, Evans DB) Surgery 2010 Dec;148(6):1311-2 PMID 21134566
  • Common locations of parathyroid adenomas. (Moreno MA, Callender GG, Woodburn K, Edeiken-Monroe BS, Grubbs EG, Evans DB, Lee JE, Perrier ND) Ann Surg Oncol 2011 Apr;18(4):1047-51 PMID 21104031
  • Reoperative parathyroidectomy: location of missed glands based on a contemporary nomenclature system. (Silberfein EJ, Bao R, Lopez A, Grubbs EG, Lee JE, Evans DB, Perrier ND) Arch Surg 2010 Nov;145(11):1065-8 PMID 21079094
  • Metastatic adult granulosa cell tumor mimicking a benign pancreatic cyst. (Abadeer RA, Fleming JB, Deavers MT, Rashid A, Evans DB, Wang H) Ann Diagn Pathol 2010 Dec;14(6):457-60 PMID 21074697
  • Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma. (Song X, Wang H, Logsdon CD, Rashid A, Fleming JB, Abbruzzese JL, Gomez HF, Evans DB, Wang H) Cancer 2011 Feb 15;117(4):734-43 PMID 20922806
  • Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy. (Evans DB, Erickson BA, Ritch P) Ann Surg Oncol 2010 Nov;17(11):2803-5 PMID 20737218
  • High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. (Liang JJ, Zhu S, Bruggeman R, Zaino RJ, Evans DB, Fleming JB, Gomez HF, Zander DS, Wang H) Cancer Epidemiol Biomarkers Prev 2010 Oct;19(10):2598-604 PMID 20732965
  • Multidisciplinary management strategy for incidental cystic lesions of the pancreas. (Bose D, Tamm E, Liu J, Marcal L, Balachandran A, Bhosale P, Fleming JB, Lee JE, Evans DB, Hwang RF) J Am Coll Surg 2010 Aug;211(2):205-15 PMID 20670858
  • High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma. (Peng L, Liang J, Wang H, Song X, Rashid A, Gomez HF, Corley LJ, Abbruzzese JL, Fleming JB, Evans DB, Wang H) Clin Cancer Res 2010 Jul 15;16(14):3734-42 PMID 20628027
  • Adult-onset hypogonadotropic hypogonadism caused by aberrant expression of aromatase in an adrenocortical adenocarcinoma. (Advani A, Johnson SJ, Nicol MR, Papacleovoulou G, Evans DB, Vaikkakara S, Mason JI, Quinton R) Endocr J 2010;57(7):651-6 PMID 20467160
  • Parathyroidectomy improves functional capacity in "asymptomatic" older patients with primary hyperparathyroidism: a randomized control trial. (Morris GS, Grubbs EG, Hearon CM, Gantela S, Lee JE, Evans DB, Holmes HM, Busaidy NL, Jimenez C, Perrier ND) Ann Surg 2010 May;251(5):832-7 PMID 20395857
  • Portal vein resection. (Christians KK, Lal A, Pappas S, Quebbeman E, Evans DB) Surg Clin North Am 2010 Apr;90(2):309-22 PMID 20362788
  • Do practice patterns reflect practice guidelines? (Yen TW, Evans DB) Ann Surg Oncol 2010 Jun;17(6):1478-80 PMID 20232162
  • Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation. (Katz MH, Varadhachary GR, Fleming JB, Wolff RA, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Sun CC, Wang H, Crane CH, Lee JH, Tamm EP, Abbruzzese JL, Evans DB) Ann Surg Oncol 2010 Jul;17(7):1794-801 PMID 20162463
  • Management of borderline resectable pancreatic cancer. (Lal A, Christians K, Evans DB) Surg Oncol Clin N Am 2010 Apr;19(2):359-70 PMID 20159519
  • Routine pre-operative ultrasonography for papillary thyroid cancer: effects on cervical recurrence. (Marshall CL, Lee JE, Xing Y, Perrier ND, Edeiken BS, Evans DB, Grubbs EG) Surgery 2009 Dec;146(6):1063-72 PMID 19958933
  • Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy. (Bhatia A, Rao A, Ang KK, Garden AS, Morrison WH, Rosenthal DI, Evans DB, Clayman G, Sherman SI, Schwartz DL) Head Neck 2010 Jul;32(7):829-36 PMID 19885924
  • Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism. (Perrier ND, Balachandran D, Wefel JS, Jimenez C, Busaidy N, Morris GS, Dong W, Jackson E, Weaver S, Gantela S, Evans DB, Grubbs EG, Lee JE) Surgery 2009 Dec;146(6):1116-22 PMID 19879613
  • Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. (Kim MP, Evans DB, Wang H, Abbruzzese JL, Fleming JB, Gallick GE) Nat Protoc 2009;4(11):1670-80 PMID 19876027
  • Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane. (Grubbs EG, Callender GG, Xing Y, Perrier ND, Evans DB, Phan AT, Lee JE) Ann Surg Oncol 2010 Jan;17(1):263-70 PMID 19851811
  • Posterior retroperitoneoscopic adrenalectomy. (Callender GG, Kennamer DL, Grubbs EG, Lee JE, Evans DB, Perrier ND) Adv Surg 2009;43:147-57 PMID 19845175
  • TrkBT1 induces liver metastasis of pancreatic cancer cells by sequestering Rho GDP dissociation inhibitor and promoting RhoA activation. (Li Z, Chang Z, Chiao LJ, Kang Y, Xia Q, Zhu C, Fleming JB, Evans DB, Chiao PJ) Cancer Res 2009 Oct 1;69(19):7851-9 PMID 19773448
  • Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy. (Williams MD, Suliburk JW, Staerkel GA, Busaidy NL, Clayman GL, Evans DB, Perrier ND) Ann Surg Oncol 2009 Nov;16(11):3146-53 PMID 19727961
  • Outpatient minimally invasive parathyroidectomy is safe for elderly patients. (Shin SH, Holmes H, Bao R, Jimenez C, Kee SS, Potylchansky E, Lee JE, Evans DB, Perrier ND) J Am Coll Surg 2009 Jun;208(6):1071-6 PMID 19476894
  • The fallen one: the inferior parathyroid gland that descends into the mediastinum. (Callender GG, Grubbs EG, Vu T, Hofstetter WL, Fleming JB, Woodburn KL, Lee JE, Evans DB, Perrier ND) J Am Coll Surg 2009 May;208(5):887-93; discussion 893-5 PMID 19476855
  • Medullary thyroid cancer: management guidelines of the American Thyroid Association. (American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells SA Jr) Thyroid 2009 Jun;19(6):565-612 PMID 19469690
  • Thyroid cancer in young adults. (Ying AK, Huh W, Bottomley S, Evans DB, Waguespack SG) Semin Oncol 2009 Jun;36(3):258-74 PMID 19460583
  • Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB. (Melisi D, Niu J, Chang Z, Xia Q, Peng B, Ishiyama S, Evans DB, Chiao PJ) Mol Cancer Res 2009 May;7(5):624-33 PMID 19435817
  • Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. (Evans DB, Farnell MB, Lillemoe KD, Vollmer C Jr, Strasberg SM, Schulick RD) Ann Surg Oncol 2009 Jul;16(7):1736-44 PMID 19387741
  • Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. (Fleming JB, Gonzalez RJ, Petzel MQ, Lin E, Morris JS, Gomez H, Lee JE, Crane CH, Pisters PW, Evans DB) Arch Surg 2009 Mar;144(3):216-21 PMID 19289659
  • Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer. (Dong X, Jiao L, Li Y, Evans DB, Wang H, Hess KR, Abbruzzese JL, Li D) J Clin Oncol 2009 Apr 1;27(10):1592-9 PMID 19237629
  • Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. (Katz MH, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, Varadhachary G, Abbruzzese JL, Crane CH, Krishnan S, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB) Ann Surg Oncol 2009 Apr;16(4):836-47 PMID 19194760
  • Pancreaticoduodenectomy and vascular resection: persistent controversy and current recommendations. (Christians K, Evans DB) Ann Surg Oncol 2009 Apr;16(4):789-91 PMID 19169752
  • The integration of chemoradiation in the care of patient with localized pancreatic cancer. (Crane CH, Varadhachary G, Settle SH, Fleming JB, Evans DB, Wolff RA) Cancer Radiother 2009 Apr;13(2):123-43 PMID 19167921
  • Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer. (Wang H, Song X, Logsdon C, Zhou G, Evans DB, Abbruzzese JL, Hamilton SR, Tan TH, Wang H) Cancer Res 2009 Feb 1;69(3):1063-70 PMID 19141650
  • Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment. (Schwartz DL, Lobo MJ, Ang KK, Morrison WH, Rosenthal DI, Ahamad A, Evans DB, Clayman G, Sherman SI, Garden AS) Int J Radiat Oncol Biol Phys 2009 Jul 15;74(4):1083-91 PMID 19095376
  • Anatomy of the superior mesenteric vein with special reference to the surgical management of first-order branch involvement at pancreaticoduodenectomy. (Katz MH, Fleming JB, Pisters PW, Lee JE, Evans DB) Ann Surg 2008 Dec;248(6):1098-102 PMID 19092356
  • The recognition and surgical management of heritable lesions of the pancreas. (Kim MP, Evans DB, Vu TM, Fleming JB) Surg Oncol Clin N Am 2009 Jan;18(1):99-119, ix PMID 19056044
  • Treatment options for metastatic neuroendocrine tumors. (Phan AT, Yao JC, Evans DB) Surgery 2008 Dec;144(6):895-8 PMID 19040994
  • Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial? (Grubbs EG, Rafeeq S, Jimenez C, Feng L, Lee JE, Evans DB, Perrier ND) Surgery 2008 Dec;144(6):852-8; discussion 858-9 PMID 19040987
  • Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. (Chen J, Li D, Killary AM, Sen S, Amos CI, Evans DB, Abbruzzese JL, Frazier ML) Ann Surg Oncol 2009 Feb;16(2):431-9 PMID 19020940
  • Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. (Liang JJ, Wang H, Rashid A, Tan TH, Hwang RF, Hamilton SR, Abbruzzese JL, Evans DB, Wang H) Clin Cancer Res 2008 Nov 1;14(21):7043-9 PMID 18981001
  • Posterior retroperitoneoscopic adrenalectomy: preferred technique for removal of benign tumors and isolated metastases. (Perrier ND, Kennamer DL, Bao R, Jimenez C, Grubbs EG, Lee JE, Evans DB) Ann Surg 2008 Oct;248(4):666-74 PMID 18936580
  • Diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer. (Santarpia L, Gagel RF, Sherman SI, Sarlis NJ, Evans DB, Hoff AO) Head Neck 2009 Mar;31(3):419-23 PMID 18798312
  • Polymorphisms of p21 and p27 jointly contribute to an earlier age at diagnosis of pancreatic cancer. (Chen J, Killary AM, Sen S, Amos CI, Evans DB, Abbruzzese JL, Frazier ML) Cancer Lett 2008 Dec 8;272(1):32-9 PMID 18694622
  • Cisplatin, fluorouracil, interferon-alpha, and radiation as adjuvant therapy for resected pancreatic cancer: is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer? (Pisters PW, Evans DB) Ann Surg 2008 Aug;248(2):152-3 PMID 18650622
  • Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. (Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, Wolff RA) J Clin Oncol 2008 Jul 20;26(21):3496-502 PMID 18640930
  • Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. (Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese JL, Evans DB) J Clin Oncol 2008 Jul 20;26(21):3487-95 PMID 18640929
  • Adjuvant therapy for adenocarcinoma of the pancreas: analysis of reported trials and recommendations for future progress. (Wolff RA, Varadhachary GR, Evans DB) Ann Surg Oncol 2008 Oct;15(10):2773-86 PMID 18612703
  • Diagnosis and management of cystic neoplasms of the pancreas: an evidence-based approach. (Katz MH, Mortenson MM, Wang H, Hwang R, Tamm EP, Staerkel G, Lee JH, Evans DB, Fleming JB) J Am Coll Surg 2008 Jul;207(1):106-20 PMID 18589369
  • Impact of preoperative thyroid ultrasonography on the surgical management of primary hyperparathyroidism. (Monroe DP, Edeiken-Monroe BS, Lee JE, Evans DB, Perrier ND) Br J Surg 2008 Aug;95(8):957-60 PMID 18574846
  • Efficacy of 4D-CT preoperative localization in 2 patients with MEN 2A. (Philip M, Guerrero MA, Evans DB, Hunter GJ, Edeiken-Monroe BS, Vu T, Perrier ND) J Surg Educ 2008 May-Jun;65(3):182-5 PMID 18571130
  • One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. (Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB) J Clin Oncol 2008 Jun 20;26(18):3063-72 PMID 18565894
  • The added value of multidisciplinary care for patients with pancreatic cancer. (Evans DB, Crane CH, Charnsangavej C, Wolff RA) Ann Surg Oncol 2008 Aug;15(8):2078-80 PMID 18546044
  • Parathyroid exploration in the reoperative neck: improved preoperative localization with 4D-computed tomography. (Mortenson MM, Evans DB, Lee JE, Hunter GJ, Shellingerhout D, Vu T, Edeiken BS, Feng L, Perrier ND) J Am Coll Surg 2008 May;206(5):888-95; discussion 895-6 PMID 18471717
  • Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. (Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, Vauthey JN, Abdalla EK, Crane CH, Wolff RA, Varadhachary GR, Hwang RF) J Am Coll Surg 2008 May;206(5):833-46; discussion 846-8 PMID 18471707
  • Current diagnosis and management of unusual pancreatic tumors. (Mortenson MM, Katz MH, Tamm EP, Bhutani MS, Wang H, Evans DB, Fleming JB) Am J Surg 2008 Jul;196(1):100-13 PMID 18466869
  • Combined EUS with FNA and ERCP for the evaluation of patients with obstructive jaundice from presumed pancreatic malignancy. (Ross WA, Wasan SM, Evans DB, Wolff RA, Trapani LV, Staerkel GA, Prindiville T, Lee JH) Gastrointest Endosc 2008 Sep;68(3):461-6 PMID 18384788
  • Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer. (Okazaki T, Jiao L, Chang P, Evans DB, Abbruzzese JL, Li D) Clin Cancer Res 2008 Apr 1;14(7):2042-8 PMID 18381943
  • Recent advances in thyroid cancer. (Grubbs EG, Rich TA, Li G, Sturgis EM, Younes MN, Myers JN, Edeiken-Monroe B, Fornage BD, Monroe DP, Staerkel GA, Williams MD, Waguespack SG, Hu MI, Cote G, Gagel RF, Cohen J, Weber RS, Anaya DA, Holsinger FC, Perrier ND, Clayman GL, Evans DB) Curr Probl Surg 2008 Mar;45(3):156-250 PMID 18346477
  • Recent advances in thyroid cancer. In brief. (Grubbs EG, Rich TA, Li G, Sturgis EM, Younes MN, Myers JN, Edeiken-Monroe B, Fornage BD, Monroe DP, Staerkel GA, Williams MD, Waguespack SG, Hu MI, Cote G, Gagel RF, Cohen J, Weber RS, Anaya DA, Holsinger FC, Perrier ND, Clayman GL, Evans DB) Curr Probl Surg 2008 Mar;45(3):149-51 PMID 18346476
  • Resectable pancreatic cancer: the role for neoadjuvant/preoperative therapy. (Evans DB, Multidisciplinary Pancreatic Cancer Study Group) HPB (Oxford) 2006;8(5):365-8 PMID 18333089
  • Tumor-node-metastasis staging of pancreatic adenocarcinoma. (Katz MH, Hwang R, Fleming JB, Evans DB) CA Cancer J Clin 2008 Mar-Apr;58(2):111-25 PMID 18272835
  • Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer. (Hwang RF, Wang H, Lara A, Gomez H, Chang T, Sieffert N, Moon Y, Ram S, Zimmerman S, Lee JH, Pisters PW, Tamm EP, Fleming JB, Abbruzzese JL, Evans DB) Ann Surg Oncol 2008 May;15(5):1356-66 PMID 18256882
  • Cancer-associated stromal fibroblasts promote pancreatic tumor progression. (Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB, Logsdon CD) Cancer Res 2008 Feb 1;68(3):918-26 PMID 18245495
  • Viability of cryopreserved parathyroid tissue: when is continued storage versus disposal indicated? (Guerrero MA, Evans DB, Lee JE, Bao R, Bereket A, Gantela S, Griffin GD, Perrier ND) World J Surg 2008 May;32(5):836-9 PMID 18228092
  • Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era. (Schwartz DL, Rana V, Shaw S, Yazbeck C, Ang KK, Morrison WH, Rosenthal DI, Hoff A, Evans DB, Clayman GL, Garden AS, Sherman SI) Head Neck 2008 Jul;30(7):883-8 PMID 18213725
  • Same-day ultrasound guidance in reoperations for locally recurrent papillary thyroid cancer. (Solorzano CC, Evans DB) Surgery 2007 Dec;142(6):973-5 PMID 18063084
  • Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma. (Gonzalez RJ, Tamm EP, Ng C, Phan AT, Vassilopoulou-Sellin R, Perrier ND, Evans DB, Lee JE) Surgery 2007 Dec;142(6):867-75; discussion 867-75 PMID 18063070
  • XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer. (Jiao L, Hassan MM, Bondy ML, Wolff RA, Evans DB, Abbruzzese JL, Li D) Am J Gastroenterol 2008 Feb;103(2):360-7 PMID 17986315
  • Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater. (Krishnan S, Rana V, Evans DB, Varadhachary G, Das P, Bhatia S, Delclos ME, Janjan NA, Wolff RA, Crane CH, Pisters PW) Int J Radiat Oncol Biol Phys 2008 Mar 1;70(3):735-43 PMID 17980502
  • Failure to recognize multiple endocrine neoplasia 2B: more common than we think? (Wray CJ, Rich TA, Waguespack SG, Lee JE, Perrier ND, Evans DB) Ann Surg Oncol 2008 Jan;15(1):293-301 PMID 17963006
  • Population-based study of islet cell carcinoma. (Yao JC, Eisner MP, Leary C, Dagohoy C, Phan A, Rashid A, Hassan M, Evans DB) Ann Surg Oncol 2007 Dec;14(12):3492-500 PMID 17896148
  • Risk factors for pancreatic cancer: case-control study. (Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, Pisters PW, Evans DB, Khan R, Chou TH, Lenzi R, Jiao L, Li D) Am J Gastroenterol 2007 Dec;102(12):2696-707 PMID 17764494
  • Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer. (Tamm EP, Loyer EM, Faria SC, Evans DB, Wolff RA, Charnsangavej C) Abdom Imaging 2007 Sep-Oct;32(5):660-7 PMID 17712589
  • Future chemoradiation strategies in pancreatic cancer. (Crane CH, Varadhachary G, Pisters PW, Evans DB, Wolff RA) Semin Oncol 2007 Aug;34(4):335-46 PMID 17674962
  • Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism. (Mittendorf EA, Wefel JS, Meyers CA, Doherty D, Shapiro SE, Lee JE, Evans DB, Perrier ND) Endocr Pract 2007 Jul-Aug;13(4):338-44 PMID 17669708
  • Followup of patients with papillary thyroid cancer: in search of the optimal algorithm. (Mittendorf EA, Wang X, Perrier ND, Francis AM, Edeiken BS, Shapiro SE, Lee JE, Evans DB) J Am Coll Surg 2007 Aug;205(2):239-47 PMID 17660070
  • Role of lymph node dissection in primary surgery for thyroid cancer. (Grubbs EG, Evans DB) J Natl Compr Canc Netw 2007 Jul;5(6):623-30 PMID 17623613
  • Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models. (Xie X, Xia W, Li Z, Kuo HP, Liu Y, Li Z, Ding Q, Zhang S, Spohn B, Yang Y, Wei Y, Lang JY, Evans DB, Chiao PJ, Abbruzzese JL, Hung MC) Cancer Cell 2007 Jul;12(1):52-65 PMID 17613436
  • Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. (Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, Hwang R, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB) Ann Surg 2007 Jul;246(1):52-60 PMID 17592291
  • Pheochromocytoma: advances in genetics, diagnosis, localization, and treatment. (Mittendorf EA, Evans DB, Lee JE, Perrier ND) Hematol Oncol Clin North Am 2007 Jun;21(3):509-25; ix PMID 17548037
  • Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy. (Krishnan S, Rana V, Janjan NA, Varadhachary GR, Abbruzzese JL, Das P, Delclos ME, Gould MS, Evans DB, Wolff RA, Crane CH) Cancer 2007 Jul 1;110(1):47-55 PMID 17538975
  • Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer. (Tamm EP et al.) Abdom Imaging 2007 May 24: PMID 17522753
  • The learning curve in pancreatic surgery. (Tseng JF, Pisters PW, Lee JE, Wang H, Gomez HF, Sun CC, Evans DB) Surgery 2007 May;141(5):694-701 PMID 17511115
  • Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation. (Reyes-Gibby CC, Chan W, Abbruzzese JL, Xiong HQ, Ho L, Evans DB, Varadhachary G, Bhat S, Wolff RA, Crane C) J Pain Symptom Manage 2007 Sep;34(3):244-52 PMID 17513082
  • Aurora-A and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in Caucasians. (Chen J, Li D, Wei C, Sen S, Killary AM, Amos CI, Evans DB, Abbruzzese JL, Frazier ML) Clin Cancer Res 2007 May 15;13(10):3100-4 PMID 17505013
  • Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study. (Hassan MM, Abbruzzese JL, Bondy ML, Wolff RA, Vauthey JN, Pisters PW, Evans DB, Khan R, Lenzi R, Jiao L, Li D) Cancer 2007 Jun 15;109(12):2547-56 PMID 17492688
  • Arterial variants in pancreatic adenocarcinoma. (Balachandran A, Darden DL, Tamm EP, Faria SC, Evans DB, Charnsangavej C) Abdom Imaging 2008 Mar-Apr;33(2):214-21 PMID 17435979
  • Dietary mutagen exposure and risk of pancreatic cancer. (Li D, Day RS, Bondy ML, Sinha R, Nguyen NT, Evans DB, Abbruzzese JL, Hassan MM) Cancer Epidemiol Biomarkers Prev 2007 Apr;16(4):655-61 PMID 17416754
  • Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death. (Uwagawa T, Li Z, Chang Z, Xia Q, Peng B, Sclabas GM, Ishiyama S, Hung MC, Evans DB, Abbruzzese JL, Chiao PJ) Cancer 2007 May 15;109(10):2142-53 PMID 17410536
  • The learning curve in pancreatic surgery. (Tseng JF, Pisters PW, Lee JE, Wang H, Gomez HF, Sun CC, Evans DB) Surgery 2007 Apr;141(4):456-63 PMID 17383522
  • Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumors. (Zhang J, Jia Z, Li Q, Wang L, Rashid A, Zhu Z, Evans DB, Vauthey JN, Xie K, Yao JC) Cancer 2007 Apr 15;109(8):1478-86 PMID 17340592
  • Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy? (Aloia TA, Lee JE, Vauthey JN, Abdalla EK, Wolff RA, Varadhachary GR, Abbruzzese JL, Crane CH, Evans DB, Pisters PW) J Am Coll Surg 2007 Mar;204(3):347-55 PMID 17324767
  • Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target. (Camp ER, Yang A, Gray MJ, Fan F, Hamilton SR, Evans DB, Hooper AT, Pereira DS, Hicklin DJ, Ellis LM) Cancer 2007 Mar 15;109(6):1030-9 PMID 17311308
  • Immunocytochemical study of the expression of mesothelin in fine-needle aspiration biopsy specimens of pancreatic adenocarcinoma. (Baruch AC, Wang H, Staerkel GA, Evans DB, Hwang RF, Krishnamurthy S) Diagn Cytopathol 2007 Mar;35(3):143-7 PMID 17304533
  • Surgical management of familial hyperparathyroidism. (Evans DB, Rich TA, Cote GJ) Ann Surg Oncol 2007 May;14(5):1525-7 PMID 17285397
  • Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer. (Jiao L, Bondy ML, Hassan MM, Chang DZ, Abbruzzese JL, Evans DB, Smolensky MH, Li D) Cancer 2007 Mar 1;109(5):840-8 PMID 17265526
  • Effects of base excision repair gene polymorphisms on pancreatic cancer survival. (Li D, Li Y, Jiao L, Chang DZ, Beinart G, Wolff RA, Evans DB, Hassan MM, Abbruzzese JL) Int J Cancer 2007 Apr 15;120(8):1748-54 PMID 17230526
  • K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking. (Jiao L, Zhu J, Hassan MM, Evans DB, Abbruzzese JL, Li D) Pancreas 2007 Jan;34(1):55-62 PMID 17198183
  • Invited commentary: medullary thyroid cancer: the importance of RET testing. (Evans DB, Shapiro SE, Cote GJ) Surgery 2007 Jan;141(1):96-9 PMID 17188173
  • On "Posterior retroperitoneoscopic adrenalectomy--results of 560 procedures in 520 patients". (Evans DB, Perrier ND) Surgery 2006 Dec;140(6):951-2 PMID 17188143
  • Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. (Rodgers SE, Hunter GJ, Hamberg LM, Schellingerhout D, Doherty DB, Ayers GD, Shapiro SE, Edeiken BS, Truong MT, Evans DB, Lee JE, Perrier ND) Surgery 2006 Dec;140(6):932-40; discussion 940-1 PMID 17188140
  • Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. (Frates MC, Benson CB, Charboneau JW, Cibas ES, Clark OH, Coleman BG, Cronan JJ, Doubilet PM, Evans DB, Goellner JR, Hay ID, Hertzberg BS, Intenzo CM, Jeffrey RB, Langer JE, Larsen PR, Mandel SJ, Middleton WD, Reading CC, Sherman SI, Tessler FN) Ultrasound Q 2006 Dec;22(4):231-8; discussion 239-40 PMID 17146329
  • Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation. (Krishnan S, Rana V, Janjan NA, Abbruzzese JL, Gould MS, Das P, Delclos ME, Palla S, Guha S, Varadhachary G, Evans DB, Wolff RA, Crane CH) Cancer 2006 Dec 1;107(11):2589-96 PMID 17083124
  • Concurrent capecitabine and upper abdominal radiation therapy is well tolerated. (Das P, Wolff RA, Abbruzzese JL, Varadhachary GR, Evans DB, Vauthey JN, Baschnagel A, Delclos ME, Krishnan S, Janjan NA, Crane CH) Radiat Oncol 2006;1:41 PMID 17062148
  • Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy. (Tamm EP et al.) Abdom Imaging 2006 Sep 12: PMID 16967235
  • Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma. (Kouvaraki MA, Korapati AL, Rassidakis GZ, Tian L, Zhang Q, Chiao P, Ho L, Evans DB, Claret FX) Cancer Res 2006 Sep 1;66(17):8581-9 PMID 16951171
  • Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cells. (Bauer TW, Somcio RJ, Fan F, Liu W, Johnson M, Lesslie DP, Evans DB, Gallick GE, Ellis LM) Mol Cancer Ther 2006 Jul;5(7):1676-82 PMID 16891453
  • Adrenocortical carcinoma. (Rodgers SE, Evans DB, Lee JE, Perrier ND) Surg Oncol Clin N Am 2006 Jul;15(3):535-53 PMID 16882496
  • Src activation of Stat3 is an independent requirement from NF-kappaB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cells. (Trevino JG, Gray MJ, Nawrocki ST, Summy JM, Lesslie DP, Evans DB, Sawyer TK, Shakespeare WC, Watowich SS, Chiao PJ, McConkey DJ, Gallick GE) Angiogenesis 2006;9(2):101-10 PMID 16871430
  • Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. (Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H, Lee JE, Pisters PW, Evans DB, Wolff RA) Ann Surg Oncol 2006 Aug;13(8):1035-46 PMID 16865597
  • Selected polymorphisms of DNA repair genes and risk of pancreatic cancer. (Jiao L, Bondy ML, Hassan MM, Wolff RA, Evans DB, Abbruzzese JL, Li D) Cancer Detect Prev 2006;30(3):284-91 PMID 16844323
  • Intraductal papillary mucinous neoplasms of the pancreas. (Al-Refaie WB, Choi EA, Tseng JF, Tamm EP, Lee JH, Lee JE, Evans DB, Pisters PW) Med Princ Pract 2006;15(4):245-52 PMID 16763389
  • Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. (Kouvaraki MA, Shapiro SE, Cote GJ, Lee JE, Yao JC, Waguespack SG, Gagel RF, Evans DB, Perrier ND) World J Surg 2006 May;30(5):643-53 PMID 16680581
  • Indications for operative intervention in patients with asymptomatic primary hyperparathyroidism: practice patterns of endocrine surgery. (Kouvaraki MA, Greer M, Sharma S, Beery D, Armand R, Lee JE, Evans DB, Perrier ND) Surgery 2006 Apr;139(4):527-34 PMID 16627063
  • Abdominal visceral lesions in von Hippel-Lindau disease: incidence and clinical behavior of pancreatic and adrenal lesions at a single center. (Delman KA, Shapiro SE, Jonasch EW, Lee JE, Curley SA, Evans DB, Perrier ND) World J Surg 2006 May;30(5):665-9 PMID 16617420
  • The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer. (Crane CH, Varadhachary G, Wolff RA, Pisters PW, Evans DB) Best Pract Res Clin Gastroenterol 2006 Apr;20(2):365-82 PMID 16549333
  • Venous resection in pancreatic cancer surgery. (Tseng JF, Tamm EP, Lee JE, Pisters PW, Evans DB) Best Pract Res Clin Gastroenterol 2006 Apr;20(2):349-64 PMID 16549332
  • Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival. (Li D, Liu H, Jiao L, Chang DZ, Beinart G, Wolff RA, Evans DB, Hassan MM, Abbruzzese JL) Cancer Res 2006 Mar 15;66(6):3323-30 PMID 16540687
  • Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. (Raut CP, Cleary KR, Staerkel GA, Abbruzzese JL, Wolff RA, Lee JH, Vauthey JN, Lee JE, Pisters PW, Evans DB) Ann Surg Oncol 2006 Apr;13(4):582-94 PMID 16523362
  • Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer. (Li D, Frazier M, Evans DB, Hess KR, Crane CH, Jiao L, Abbruzzese JL) J Clin Oncol 2006 Apr 10;24(11):1720-8 PMID 16520463
  • Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. (Crane CH, Ellis LM, Abbruzzese JL, Amos C, Xiong HQ, Ho L, Evans DB, Tamm EP, Ng C, Pisters PW, Charnsangavej C, Delclos ME, O'Reilly M, Lee JE, Wolff RA) J Clin Oncol 2006 Mar 1;24(7):1145-51 PMID 16505434
  • Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy. (Tamm EP, Loyer EM, Faria S, Raut CP, Evans DB, Wolff RA, Crane CH, Dubrow RA, Charnsangavej C) Abdom Imaging 2006 Sep-Oct;31(5):568-74 PMID 16465578
  • The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk. (Jiao L, Hassan MM, Bondy ML, Abbruzzese JL, Evans DB, Li D) Cancer Lett 2007 Jan 8;245(1-2):61-8 PMID 16458430
  • Preoperative chemoradiation for pancreatic cancer. (Evans DB) Semin Oncol 2005 Dec;32(6 Suppl 9):S25-9 PMID 16399426
  • Laparoscopic resection of adrenal cortical carcinoma: a cautionary note. (Gonzalez RJ, Shapiro S, Sarlis N, Vassilopoulou-Sellin R, Perrier ND, Evans DB, Lee JE) Surgery 2005 Dec;138(6):1078-85; discussion 1085-6 PMID 16360394
  • Carcinoid tumors of the duodenum. (Mullen JT, Wang H, Yao JC, Lee JH, Perrier ND, Pisters PW, Lee JE, Evans DB) Surgery 2005 Dec;138(6):971-7; discussion 977-8 PMID 16360380
  • Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. (Frates MC, Benson CB, Charboneau JW, Cibas ES, Clark OH, Coleman BG, Cronan JJ, Doubilet PM, Evans DB, Goellner JR, Hay ID, Hertzberg BS, Intenzo CM, Jeffrey RB, Langer JE, Larsen PR, Mandel SJ, Middleton WD, Reading CC, Sherman SI, Tessler FN, Society of Radiologists in Ultrasound) Radiology 2005 Dec;237(3):794-800 PMID 16304103
  • Pancreaticoduodenectomy after placement of endobiliary metal stents. (Mullen JT, Lee JH, Gomez HF, Ross WA, Fukami N, Wolff RA, Abdalla EK, Vauthey JN, Lee JE, Pisters PW, Evans DB) J Gastrointest Surg 2005 Nov;9(8):1094-104; discussion 1104-5 PMID 16269380
  • Borderline resectable pancreatic cancer. (Varadhachary GR, Tamm EP, Crane C, Evans DB, Wolff RA) Curr Treat Options Gastroenterol 2005 Oct;8(5):377-84 PMID 16162303
  • Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. (Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM) Cancer Res 2005 Sep 1;65(17):7775-81 PMID 16140945
  • RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors. (Kouvaraki MA, Shapiro SE, Perrier ND, Cote GJ, Gagel RF, Hoff AO, Sherman SI, Lee JE, Evans DB) Thyroid 2005 Jun;15(6):531-44 PMID 16029119
  • Surgical management of thyroid carcinoma. (Kouvaraki MA, Shapiro SE, Lee JE, Evans DB, Perrier ND) J Natl Compr Canc Netw 2005 May;3(3):458-66 PMID 16002007
  • Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. (Li D, Jiao L, Li Y, Doll MA, Hein DW, Bondy ML, Evans DB, Wolff RA, Lenzi R, Pisters PW, Abbruzzese JL, Hassan MM) Carcinogenesis 2006 Jan;27(1):103-11 PMID 15987714
  • Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. (Pawlik TM, Abdalla EK, Barnett CC, Ahmad SA, Cleary KR, Vauthey JN, Lee JE, Evans DB, Pisters PW) Arch Surg 2005 Jun;140(6):584-9; discussion 589-91 PMID 15967906
  • Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells. (Wey JS, Gray MJ, Fan F, Belcheva A, McCarty MF, Stoeltzing O, Somcio R, Liu W, Evans DB, Klagsbrun M, Gallick GE, Ellis LM) Br J Cancer 2005 Jul 25;93(2):233-41 PMID 15956974
  • Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines. (Wey JS, Fan F, Gray MJ, Bauer TW, McCarty MF, Somcio R, Liu W, Evans DB, Wu Y, Hicklin DJ, Ellis LM) Cancer 2005 Jul 15;104(2):427-38 PMID 15952180
  • 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer. (Li D, Ahmed M, Li Y, Jiao L, Chou TH, Wolff RA, Lenzi R, Evans DB, Bondy ML, Pisters PW, Abbruzzese JL, Hassan MM) Cancer Epidemiol Biomarkers Prev 2005 Jun;14(6):1470-6 PMID 15941958
  • Radiation dose considerations in the palliative treatment of locally advanced adenocarcinoma of the pancreas. (Wong AA, Delclos ME, Wolff RA, Evans DB, Abbruzzese JL, Tamm EP, Xiong HQ, Ho L, Crane CH, Pancreatic Tumor Study Group) Am J Clin Oncol 2005 Jun;28(3):227-33 PMID 15923793
  • Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors. (Gray MJ, Wey JS, Belcheva A, McCarty MF, Trevino JG, Evans DB, Ellis LM, Gallick GE) Cancer Res 2005 May 1;65(9):3664-70 PMID 15867361
  • Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin. (Sclabas GM, Uwagawa T, Schmidt C, Hess KR, Evans DB, Abbruzzese JL, Chiao PJ) Cancer 2005 Jun 15;103(12):2485-90 PMID 15861417
  • Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1. (Lambert LA, Shapiro SE, Lee JE, Perrier ND, Truong M, Wallace MJ, Hoff AO, Gagel RF, Evans DB) Arch Surg 2005 Apr;140(4):374-82 PMID 15841561
  • Combined-modality treatment for operable pancreatic adenocarcinoma. (Pisters PW, Wolff RA, Crane CH, Evans DB) Oncology (Williston Park) 2005 Mar;19(3):393-404, 409; discussion 409-10, 412-6 PMID 15828554
  • HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. (Gray MJ, Zhang J, Ellis LM, Semenza GL, Evans DB, Watowich SS, Gallick GE) Oncogene 2005 Apr 28;24(19):3110-20 PMID 15735682
  • Surgical treatment of non-functioning pancreatic islet cell tumors. (Kouvaraki MA, Solorzano CC, Shapiro SE, Yao JC, Perrier ND, Lee JE, Evans DB) J Surg Oncol 2005 Mar 1;89(3):170-85 PMID 15719379
  • Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells. (Sclabas GM, Fujioka S, Schmidt C, Li Z, Frederick WA, Yang W, Yokoi K, Evans DB, Abbruzzese JL, Hess KR, Zhang W, Fidler IJ, Chiao PJ) Clin Cancer Res 2005 Jan 15;11(2 Pt 1):440-9 PMID 15701826
  • Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. (Kouvaraki MA, Lee JE, Shapiro SE, Sherman SI, Evans DB) Surgery 2004 Dec;136(6):1183-91 PMID 15657574
  • Pancreaticoduodenectomy with vascular resection: margin status and survival duration. (Tseng JF, Raut CP, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Gomez HF, Sun CC, Crane CH, Wolff RA, Evans DB) J Gastrointest Surg 2004 Dec;8(8):935-49; discussion 949-50 PMID 15585381
  • Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas. (Kouvaraki MA, Ajani JA, Hoff P, Wolff R, Evans DB, Lozano R, Yao JC) J Clin Oncol 2004 Dec 1;22(23):4762-71 PMID 15570077
  • Neoadjuvant therapy for resectable pancreatic cancer. (Raut CP, Evans DB, Crane CH, Pisters PW, Wolff RA) Surg Oncol Clin N Am 2004 Oct;13(4):639-61, ix PMID 15350939
  • Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation. (Jimenez C, Habra MA, Huang SC, El-Naggar A, Shapiro SE, Evans DB, Cote G, Gagel RF) J Clin Endocrinol Metab 2004 Aug;89(8):4142-5 PMID 15292360
  • Parathyroid carcinoma: a 22-year experience. (Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, Asper JA, Diaz EM Jr, Evans DB, Gagel RF, Garden A, Hoff AO, Lee JE, Morrison WH, Rosenthal DI, Sherman SI, Sturgis EM, Waguespack SG, Weber RS, Wirfel K, Vassilopoulou-Sellin R) Head Neck 2004 Aug;26(8):716-26 PMID 15287039
  • A novel point mutation of the RET protooncogene involving the second intracellular tyrosine kinase domain in a family with medullary thyroid carcinoma. (Jimenez C, Dang GT, Schultz PN, El-Naggar A, Shapiro S, Barnes EA, Evans DB, Vassilopoulou-Sellin R, Gagel RF, Cote GJ, Hoff AO) J Clin Endocrinol Metab 2004 Jul;89(7):3521-6 PMID 15240641
  • Surgical and endoscopic palliation for pancreatic cancer. (Andtbacka RH, Evans DB, Pisters PW) Minerva Chir 2004 Apr;59(2):123-36 PMID 15238887
  • Overexpression of synuclein-gamma in pancreatic adenocarcinoma. (Li Z, Sclabas GM, Peng B, Hess KR, Abbruzzese JL, Evans DB, Chiao PJ) Cancer 2004 Jul 1;101(1):58-65 PMID 15221989
  • Fine-needle aspiration cytology of mucinous tumors of the pancreas. (Recine M, Kaw M, Evans DB, Krishnamurthy S) Cancer 2004 Apr 25;102(2):92-9 PMID 15098253
  • Surgical management of hereditary pheochromocytoma. (Yip L, Lee JE, Shapiro SE, Waguespack SG, Sherman SI, Hoff AO, Gagel RF, Arens JF, Evans DB) J Am Coll Surg 2004 Apr;198(4):525-34; discussion 534-5 PMID 15051000
  • The role of intraoperative radiotherapy in pancreatic cancer. (Crane CH, Beddar AS, Evans DB) Surg Oncol Clin N Am 2003 Oct;12(4):965-77 PMID 14989127
  • Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model. (Hwang RF, Yokoi K, Bucana CD, Tsan R, Killion JJ, Evans DB, Fidler IJ) Clin Cancer Res 2003 Dec 15;9(17):6534-44 PMID 14695158
  • Potential role for intraoperative gamma probe identification of normal parathyroid glands. (Pederson LC, Shapiro SE, Fritsche HA Jr, Delpassand ES, Gagel RF, Sherman SI, Vassilopoulou-Sellin R, Evans DB, Lee JE) Am J Surg 2003 Dec;186(6):711-7 PMID 14672784
  • Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients. (Sclabas GM, Staerkel GA, Shapiro SE, Fornage BD, Sherman SI, Vassillopoulou-Sellin R, Lee JE, Evans DB) Am J Surg 2003 Dec;186(6):702-9; discussion 709-10 PMID 14672783
  • Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients. (Yen TW, Shapiro SE, Gagel RF, Sherman SI, Lee JE, Evans DB) Surgery 2003 Dec;134(6):890-9; discussion 899-901 PMID 14668720
  • Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. (Kouvaraki MA, Shapiro SE, Fornage BD, Edeiken-Monro BS, Sherman SI, Vassilopoulou-Sellin R, Lee JE, Evans DB) Surgery 2003 Dec;134(6):946-54; discussion 954-5 PMID 14668727
  • Mechanisms of proinflammatory cytokine-induced biphasic NF-kappaB activation. (Schmidt C, Peng B, Li Z, Sclabas GM, Fujioka S, Niu J, Schmidt-Supprian M, Evans DB, Abbruzzese JL, Chiao PJ) Mol Cell 2003 Nov;12(5):1287-300 PMID 14636585
  • The role of genetics in the surgical management of familial endocrinopathy syndromes. (Shapiro SE, Cote GC, Lee JE, Gagel RF, Evans DB) J Am Coll Surg 2003 Nov;197(5):818-31 PMID 14585420
  • Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer. (Stoeltzing O, Liu W, Reinmuth N, Fan F, Parikh AA, Bucana CD, Evans DB, Semenza GL, Ellis LM) Am J Pathol 2003 Sep;163(3):1001-11 PMID 12937141
  • Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin-1 by epidermal growth factor in human pancreatic carcinoma. (Parikh AA, Liu WB, Fan F, Stoeltzing O, Reinmuth N, Bruns CJ, Bucana CD, Evans DB, Ellis LM) Cancer 2003 Aug 15;98(4):720-9 PMID 12910515
  • NF-kappaB in pancreatic cancer. (Sclabas GM, Fujioka S, Schmidt C, Evans DB, Chiao PJ) Int J Gastrointest Cancer 2003;33(1):15-26 PMID 12909735
  • Novel applications of endo GIA linear staplers during pancreaticoduodenectomy and total pancreatectomy. (Evans DB, Pisters PW) Am J Surg 2003 Jun;185(6):606-7 PMID 12781900
  • Administration of optimal biological dose and schedule of interferon alpha combined with gemcitabine induces apoptosis in tumor-associated endothelial cells and reduces growth of human pancreatic carcinoma implanted orthotopically in nude mice. (Solorzano CC, Hwang R, Baker CH, Bucana CD, Pisters PW, Evans DB, Killion JJ, Fidler IJ) Clin Cancer Res 2003 May;9(5):1858-67 PMID 12738744
  • Diagnosis, staging, and surveillance of pancreatic cancer. (Tamm EP, Silverman PM, Charnsangavej C, Evans DB) AJR Am J Roentgenol 2003 May;180(5):1311-23 PMID 12704043
  • Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. (Yip L, Cote GJ, Shapiro SE, Ayers GD, Herzog CE, Sellin RV, Sherman SI, Gagel RF, Lee JE, Evans DB) Arch Surg 2003 Apr;138(4):409-16; discussion 416 PMID 12686527
  • Comment and perspective on Sewnath and colleagues' recent meta-analysis of the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. (Pisters PW, Lee JE, Vauthey JN, Evans DB) Ann Surg 2003 Apr;237(4):594-5; author reply 595-6 PMID 12677158
  • Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. (Li D, Zhu J, Firozi PF, Abbruzzese JL, Evans DB, Cleary K, Friess H, Sen S) Clin Cancer Res 2003 Mar;9(3):991-7 PMID 12631597
  • Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis. (Fujioka S, Sclabas GM, Schmidt C, Niu J, Frederick WA, Dong QG, Abbruzzese JL, Evans DB, Baker C, Chiao PJ) Oncogene 2003 Mar 6;22(9):1365-70 PMID 12618762
  • Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. (Raut CP, Grau AM, Staerkel GA, Kaw M, Tamm EP, Wolff RA, Vauthey JN, Lee JE, Pisters PW, Evans DB) J Gastrointest Surg 2003 Jan;7(1):118-26; discussion 127-8 PMID 12559193
  • Restoring apoptosis in pancreatic cancer cells by targeting the nuclear factor-kappaB signaling pathway with the anti-epidermal growth factor antibody IMC-C225. (Sclabas GM, Fujioka S, Schmidt C, Fan Z, Evans DB, Chiao PJ) J Gastrointest Surg 2003 Jan;7(1):37-43; discussion 43 PMID 12559183
  • Pancreatic leak after left pancreatectomy is reduced following main pancreatic duct ligation. (Bilimoria MM, Cormier JN, Mun Y, Lee JE, Evans DB, Pisters PW) Br J Surg 2003 Feb;90(2):190-6 PMID 12555295
  • Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head. (Crane CH, Antolak JA, Rosen II, Forster KM, Evans DB, Janjan NA, Charnsangavej C, Pisters PW, Lenzi R, Papagikos MA, Wolff RA) Int J Gastrointest Cancer 2001;30(3):123-32 PMID 12540024
  • Function of nuclear factor kappaB in pancreatic cancer metastasis. (Fujioka S, Sclabas GM, Schmidt C, Frederick WA, Dong QG, Abbruzzese JL, Evans DB, Baker C, Chiao PJ) Clin Cancer Res 2003 Jan;9(1):346-54 PMID 12538487
  • Subaquatic laparoscopy for staging of intraabdominal malignancy. (Abdalla EK, Barnett CC, Pisters PW, Cleary KR, Evans DB, Feig BW, Mansfield PF) J Am Coll Surg 2003 Jan;196(1):155-8 PMID 12517569
  • Improving the yield of preoperative parathyroid localization: technetium Tc 99m-sestamibi imaging after thyroid suppression. (Royal RE, Delpassand ES, Shapiro SE, Fritsche HA Jr, Vassilopoulou-Sellin R, Sherman SI, Gagel RF, Evans DB, Lee JE) Surgery 2002 Dec;132(6):968-74; discussion 974-5 PMID 12490843
  • Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells. (Peng B, Fleming JB, Breslin T, Grau AM, Fojioka S, Abbruzzese JL, Evans DB, Ayers D, Wathen K, Wu T, Robertson KD, Chiao PJ) Clin Cancer Res 2002 Nov;8(11):3628-38 PMID 12429655
  • ESPAC-1 trial of adjuvant therapy for resectable adenocarcinoma of the pancreas. (Evans DB, Hess KR, Pisters PW) Ann Surg 2002 Nov;236(5):694; author reply 694-6 PMID 12409677
  • The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis. (Dong QG, Sclabas GM, Fujioka S, Schmidt C, Peng B, Wu T, Tsao MS, Evans DB, Abbruzzese JL, McDonnell TJ, Chiao PJ) Oncogene 2002 Sep 19;21(42):6510-9 PMID 12226754
  • Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy. (Lenzi R, Yalcin S, Evans DB, Abbruzzese JL) Cancer Invest 2002;20(4):464-72 PMID 12094541
  • Genotype-phenotype analysis in multiple endocrine neoplasia type 1. (Kouvaraki MA, Lee JE, Shapiro SE, Gagel RF, Sherman SI, Sellin RV, Cote GJ, Evans DB) Arch Surg 2002 Jun;137(6):641-7 PMID 12049533
  • Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome. (Pisters PW, Wolff RA, Janjan NA, Cleary KR, Charnsangavej C, Crane CN, Lenzi R, Vauthey JN, Lee JE, Abbruzzese JL, Evans DB) J Clin Oncol 2002 May 15;20(10):2537-44 PMID 12011133
  • Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? (Crane CH, Abbruzzese JL, Evans DB, Wolff RA, Ballo MT, Delclos M, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong AB, Phan T, Nguyen Q, Janjan NA) Int J Radiat Oncol Biol Phys 2002 Apr 1;52(5):1293-302 PMID 11955742
  • Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation. (Wayne JD, Abdalla EK, Wolff RA, Crane CH, Pisters PW, Evans DB) Oncologist 2002;7(1):34-45 PMID 11854545
  • Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. (Solorzano CC, Lee JE, Pisters PW, Vauthey JN, Ayers GD, Jean ME, Gagel RF, Ajani JA, Wolff RA, Evans DB) Surgery 2001 Dec;130(6):1078-85 PMID 11742342
  • Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy. (Lenert JT, Barnett CC Jr, Kudelka AP, Sellin RV, Gagel RF, Prieto VG, Skibber JM, Ross MI, Pisters PW, Curley SA, Evans DB, Lee JE) Surgery 2001 Dec;130(6):1060-7 PMID 11742339
  • Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis. (Esnaola NF, Cantor SB, Sherman SI, Lee JE, Evans DB) Surgery 2001 Dec;130(6):921-30 PMID 11742318
  • Adrenal cortical carcinoma. (Dackiw AP, Lee JE, Gagel RF, Evans DB) World J Surg 2001 Jul;25(7):914-26 PMID 11572033
  • Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. (Crane CH, Janjan NA, Evans DB, Wolff RA, Ballo MT, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong A, Phan T, Nguyen Q, Abbruzzese JL) Int J Pancreatol 2001;29(1):9-18 PMID 11560155
  • Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index. (Crane CH, Wolff RA, Abbruzzese JL, Evans DB, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Lahoti S, Vauthey JN, Janjan NA) Semin Oncol 2001 Jun;28(3 Suppl 10):25-33 PMID 11510031
  • Multimodality management of localized pancreatic cancer. (Wayne JD, Wolff RA, Pisters PW, Evans DB) Cancer J 2001 Jul-Aug;7 Suppl 1:S35-46 PMID 11504284
  • Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. (Wolff RA, Evans DB, Gravel DM, Lenzi R, Pisters PW, Lee JE, Janjan NA, Charnsangavej C, Abbruzzese JL) Clin Cancer Res 2001 Aug;7(8):2246-53 PMID 11489798
  • Preoperative chemoradiation therapy for pancreatic cancer. (Evans DB, Pisters PW) Surg Clin North Am 2001 Jun;81(3):709-13 PMID 11459284
  • Neoadjuvant strategies for pancreatic cancer. (Evans DB, Wolff RA, Crane CH) Oncology (Williston Park) 2001 Jun;15(6):727-37; discussion 741-4, 747 PMID 11430206
  • Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. (Pisters PW, Hudec WA, Hess KR, Lee JE, Vauthey JN, Lahoti S, Raijman I, Evans DB) Ann Surg 2001 Jul;234(1):47-55 PMID 11420482
  • Preoperative chemoradiation for resectable and locally advanced adenocarcinoma of the pancreas. (Evans DB) J Gastrointest Surg 2001 Jan-Feb;5(1):2-5 PMID 11370617
  • Re: Surgery for ductal adenocarcinoma of the pancreatic head. (Pisters PW, Evans DB, Leung DH, Brennan MF) World J Surg 2001 Apr;25(4):533-4 PMID 11344412
  • Laparoscopy in the staging of pancreatic cancer. (Pisters PW, Lee JE, Vauthey JN, Charnsangavej C, Evans DB) Br J Surg 2001 Mar;88(3):325-37 PMID 11260096
  • Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. (Breslin TM, Hess KR, Harbison DB, Jean ME, Cleary KR, Dackiw AP, Wolff RA, Abbruzzese JL, Janjan NA, Crane CH, Vauthey JN, Lee JE, Pisters PW, Evans DB) Ann Surg Oncol 2001 Mar;8(2):123-32 PMID 11258776
  • Limitations of size as a criterion in the evaluation of adrenal tumors. (Barnett CC Jr, Varma DG, El-Naggar AK, Dackiw AP, Porter GA, Pearson AS, Kudelka AP, Gagel RF, Evans DB, Lee JE) Surgery 2000 Dec;128(6):973-82;discussion 982-3 PMID 11114632
  • Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region. (Evans DB, Wolff RA, Hess KR) Ann Surg 2000 Nov;232(5):727 PMID 11066157
  • Cost and utilization impact of a clinical pathway for patients undergoing pancreaticoduodenectomy. (Porter GA, Pisters PW, Mansyur C, Bisanz A, Reyna K, Stanford P, Lee JE, Evans DB) Ann Surg Oncol 2000 Aug;7(7):484-9 PMID 10947015
  • The detection of telomerase activity in patients with adenocarcinoma of the pancreas by fine needle aspiration. (Pearson AS, Chiao P, Zhang L, Zhang W, Larry L, Katz RL, Evans DB, Abbruzzese JL) Int J Oncol 2000 Aug;17(2):381-5 PMID 10891550
  • Thyroid cancer: 1999 update. (Tyler DS, Shaha AR, Udelsman RA, Sherman SI, Thompson NW, Moley JF, Evans DB) Ann Surg Oncol 2000 Jun;7(5):376-98 PMID 10864346
  • Significance and management of local recurrences and limited metastatic disease in the abdomen. (Windham TC, Pearson AS, Skibber JM, Mansfield PF, Lee JE, Pisters PW, Evans DB) Surg Clin North Am 2000 Apr;80(2):761-74, xii PMID 10836016
  • Current approaches and future strategies for pancreatic carcinoma. (Wolff RA, Chiao P, Lenzi R, Pisters PW, Lee JE, Janjan NA, Crane CH, Evans DB, Abbruzzese JL) Invest New Drugs 2000 Feb;18(1):43-56 PMID 10830140
  • Gut peptide receptor expression in human pancreatic cancers. (Ehlers RA, Kim Sh, Zhang Y, Ethridge RT, Murrilo C, Hellmich MR, Evans DB, Townsend CM Jr, Mark Evers B) Ann Surg 2000 Jun;231(6):838-48 PMID 10816627
  • Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. (Bruns CJ, Harbison MT, Davis DW, Portera CA, Tsan R, McConkey DJ, Evans DB, Abbruzzese JL, Hicklin DJ, Radinsky R) Clin Cancer Res 2000 May;6(5):1936-48 PMID 10815919
  • Relative contributions of technetium Tc 99m sestamibi scintigraphy, intraoperative gamma probe detection, and the rapid parathyroid hormone assay to the surgical management of hyperparathyroidism. (Dackiw AP, Sussman JJ, Fritsche HA Jr, Delpassand ES, Stanford P, Hoff A, Gagel RF, Evans DB, Lee JE) Arch Surg 2000 May;135(5):550-5; discussion 555-7 PMID 10807279
  • Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents. (Pisters PW, Hudec WA, Lee JE, Raijman I, Lahoti S, Janjan NA, Rich TA, Crane CH, Lenzi R, Wolff RA, Abbruzzese JL, Evans DB) J Clin Oncol 2000 Feb;18(4):860-7 PMID 10673529
  • Five novel mutations in the familial multiple endocrine neoplasia type 1 (MEN1) gene. Mutations in brief no. 188. Online. (Cote GJ, Lee JE, Evans DB, Huang E, Schultz PN, Dang GT, Qiu H, Shetelbine S, Sellin RV, Gagel RF) Hum Mutat 1998;12(3):219 PMID 10660339
  • Surgical oncology. (Evans DB) J Am Coll Surg 2000 Feb;190(2):215-26 PMID 10656559
  • A multispecialty approach to the diagnosis and management of pancreatic cancer. (Hawes RH, Xiong Q, Waxman I, Chang KJ, Evans DB, Abbruzzese JL) Am J Gastroenterol 2000 Jan;95(1):17-31 PMID 10638554
  • ATP site-directed competitive and irreversible inhibitors of protein kinases. (García-Echeverría C, Traxler P, Evans DB) Med Res Rev 2000 Jan;20(1):28-57 PMID 10608920
  • Screening for MEN1 mutations in patients with atypical endocrine neoplasia. (Dackiw AP, Cote GJ, Fleming JB, Schultz PN, Stanford P, Vassilopoulou-Sellin R, Evans DB, Gagel RF, Lee JE) Surgery 1999 Dec;126(6):1097-103; discussion 1103-4 PMID 10598193
  • Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma. (Ajani JA, Mansfield PF, Lynch PM, Pisters PW, Feig B, Dumas P, Evans DB, Raijman I, Hargraves K, Curley S, Ota DM) J Clin Oncol 1999 Aug;17(8):2403-11 PMID 10561303
  • Surgical strategy for the treatment of medullary thyroid carcinoma. (Fleming JB, Lee JE, Bouvet M, Schultz PN, Sherman SI, Sellin RV, Friend KE, Burgess MA, Cote GJ, Gagel RF, Evans DB) Ann Surg 1999 Nov;230(5):697-707 PMID 10561095
  • Prognostic factors in resectable pancreatic cancer: p53 and bcl-2. (Bold RJ, Hess KR, Pearson AS, Grau AM, Sinicrope FA, Jennings M, McConkey DJ, Bucana CD, Cleary KR, Hallin PA, Chiao PJ, Abbruzzese JL, Evans DB) J Gastrointest Surg 1999 May-Jun;3(3):263-77 PMID 10481119
  • Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis. (Bold RJ, Charnsangavej C, Cleary KR, Jennings M, Madray A, Leach SD, Abbruzzese JL, Pisters PW, Lee JE, Evans DB) J Gastrointest Surg 1999 May-Jun;3(3):233-43 PMID 10481116
  • Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA. (Wang W, Abbruzzese JL, Evans DB, Chiao PJ) Oncogene 1999 Aug 12;18(32):4554-63 PMID 10467400
  • Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle. (Chiao PJ, Hunt KK, Grau AM, Abramian A, Fleming J, Zhang W, Breslin T, Abbruzzese JL, Evans DB) Ann N Y Acad Sci 1999 Jun 30;880:31-7 PMID 10415848
  • Chemoradiation for localized pancreatic cancer: another perspective. (Evans DB, Abbruzzese JL) Ann Surg Oncol 1999 Jan-Feb;6(1):4-7 PMID 10030405
  • The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. (Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ) Clin Cancer Res 1999 Jan;5(1):119-27 PMID 9918209
  • Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma. (Kuniyasu H, Ellis LM, Evans DB, Abbruzzese JL, Fenoglio CJ, Bucana CD, Cleary KR, Tahara E, Fidler IJ) Clin Cancer Res 1999 Jan;5(1):25-33 PMID 9918199
  • The surgical treatment of medullary thyroid carcinoma. (Evans DB, Fleming JB, Lee JE, Cote G, Gagel RF) Semin Surg Oncol 1999 Jan-Feb;16(1):50-63 PMID 9890740
  • Preoperative chemoradiation strategies for localized adenocarcinoma of the pancreas. (Evans DB, Pisters PW, Lee JE, Bold RJ, Charnsangavej C, Janjan NA, Wolff RA, Abbruzzese JL) J Hepatobiliary Pancreat Surg 1998;5(3):242-50 PMID 9880770
  • Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]. (Bouvet M, Bold RJ, Lee J, Evans DB, Abbruzzese JL, Chiao PJ, McConkey DJ, Chandra J, Chada S, Fang B, Roth JA) Ann Surg Oncol 1998 Dec;5(8):681-8 PMID 9869513
  • Overexpression of the tumor suppressor gene Smad4/DPC4 induces p21waf1 expression and growth inhibition in human carcinoma cells. (Hunt KK, Fleming JB, Abramian A, Zhang L, Evans DB, Chiao PJ) Cancer Res 1998 Dec 15;58(24):5656-61 PMID 9865717
  • Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomas. (Lee JE, Evans DB, Hickey RC, Sherman SI, Gagel RF, Abbruzzese MC, Abbruzzese JL) Surgery 1998 Dec;124(6):1115-22 PMID 9854592
  • Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. (Pisters PW, Abbruzzese JL, Janjan NA, Cleary KR, Charnsangavej C, Goswitz MS, Rich TA, Raijman I, Wolff RA, Lenzi R, Lee JE, Evans DB) J Clin Oncol 1998 Dec;16(12):3843-50 PMID 9850029
  • Gene therapy and pancreatic cancer. (Pearson AS, Bouvet M, Evans DB, Roth JA) Front Biosci 1998 Nov 1;3:E230-7 PMID 9792901
  • Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. (Breslin TM, Janjan NA, Lee JE, Pisters PW, Wolff RA, Abbruzzese JL, Evans DB) Front Biosci 1998 Nov 1;3:E193-203 PMID 9792895
  • Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. (Miller AR, Pisters PW, Lee JE, Janjan NA, Abbruzzese JL, Evans DB) Hepatogastroenterology 1998 May-Jun;45(21):624-33 PMID 9684107
  • Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. (Leach SD, Lee JE, Charnsangavej C, Cleary KR, Lowy AM, Fenoglio CJ, Pisters PW, Evans DB) Br J Surg 1998 May;85(5):611-7 PMID 9635805
  • Cell cycle regulation of human pancreatic cancer by tamoxifen. (Robinson EK, Grau AM, Evans DB, Smid CM, Chiao PJ, Abbruzzese JL, Grimm EA) Ann Surg Oncol 1998 Jun;5(4):342-9 PMID 9641456
  • Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma. (Ellis LM, Takahashi Y, Fenoglio CJ, Cleary KR, Bucana CD, Evans DB) Eur J Cancer 1998 Feb;34(3):337-40 PMID 9640218
  • Primary pancreatic lymphoma. (Bouvet M, Staerkel GA, Spitz FR, Curley SA, Charnsangavej C, Hagemeister FB, Janjan NA, Pisters PW, Evans DB) Surgery 1998 Apr;123(4):382-90 PMID 9551063
  • Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. (Miller AR, Robinson EK, Lee JE, Pisters PW, Chiao PJ, Lenzi RL, Abbruzzese JL, Evans DB) Surg Oncol Clin N Am 1998 Jan;7(1):183-97 PMID 9443995
  • DNA adducts in human pancreatic tissues and their potential role in carcinogenesis. (Wang M, Abbruzzese JL, Friess H, Hittelman WN, Evans DB, Abbruzzese MC, Chiao P, Li D) Cancer Res 1998 Jan 1;58(1):38-41 PMID 9426054
  • Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. (McMasters KM, Tuttle TM, Leach SD, Rich T, Cleary KR, Evans DB, Curley SA) Am J Surg 1997 Dec;174(6):605-8; discussion 608-9 PMID 9409582
  • Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. (Lowy AM, Lee JE, Pisters PW, Davidson BS, Fenoglio CJ, Stanford P, Jinnah R, Evans DB) Ann Surg 1997 Nov;226(5):632-41 PMID 9389397
  • Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. (Grau AM, Zhang L, Wang W, Ruan S, Evans DB, Abbruzzese JL, Zhang W, Chiao PJ) Cancer Res 1997 Sep 15;57(18):3929-34 PMID 9307274
  • Evaluation of the incidental adrenal mass. (Lee JE, Evans DB, Sherman SI, Gagel RF) Am J Med 1997 Sep;103(3):249-50 PMID 9316558
  • Pancreatic cancer surgical practice guidelines. Pancreatic Cancer Practice Guideline Committee. (Evans DB, Jessup JM, Colacchio T) Oncology (Williston Park) 1997 Jul;11(7):1074-9 PMID 9251127
  • Gastric cancer surgical practice guidelines. Gastric Cancer Practice Guideline Committee. (Evans DB, Jessup JM, Colacchio T) Oncology (Williston Park) 1997 Jul;11(7):1067-72 PMID 9251126
  • Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer. (Abbruzzese JL, Evans DB, Raijman I, Larry L, King T, Leach SD, Frazier ML) Anticancer Res 1997 Mar-Apr;17(2A):795-801 PMID 9137410
  • The multidisciplinary structured clinical instruction module as a vehicle for cancer education. (Sloan DA, Donnelly MB, Schwartz RW, Plymale MA, Strodel WE, Kenady DE, McGrath PC, Edwards MJ, Singletary SE, Evans DB, Souba WW, Bland KI) Am J Surg 1997 Mar;173(3):220-5 PMID 9124631
  • Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. (Spitz FR, Abbruzzese JL, Lee JE, Pisters PW, Lowy AM, Fenoglio CJ, Cleary KR, Janjan NA, Goswitz MS, Rich TA, Evans DB) J Clin Oncol 1997 Mar;15(3):928-37 PMID 9060530
  • Advances in the diagnosis and treatment of gastrointestinal neuroendocrine tumors. (Lee JE, Evans DB) Cancer Treat Res 1997;90:227-38 PMID 9367086
  • Advances in the diagnosis and treatment of adenocarcinoma of the pancreas. (Evans DB, Lee JE, Pisters PW, Charnsangavej C, Ellis LM, Chiao PJ, Lenzi R, Abbruzzese JL) Cancer Treat Res 1997;90:109-25 PMID 9367080
  • Medullary thyroid carcinoma. (Evans DB, Burgess MA, Goepfert H, Gagel RF) Curr Ther Endocrinol Metab 1997;6:127-32 PMID 9174720
  • bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome. (Sinicrope FA, Evans DB, Leach SD, Cleary KR, Fenoglio CJ, Lee JJ, Abbruzzese JL) Clin Cancer Res 1996 Dec;2(12):2015-22 PMID 9816161
  • Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma. (Lee JE, Curley SA, Gagel RF, Evans DB, Hickey RC) Surgery 1996 Dec;120(6):1064-70; discussion 1070-1 PMID 8957496
  • Reoperative pancreaticoduodenectomy for periampullary carcinoma. (Robinson EK, Lee JE, Lowy AM, Fenoglio CJ, Pisters PW, Evans DB) Am J Surg 1996 Nov;172(5):432-7; discussion 437-8 PMID 8942539
  • Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. (Wohllk N, Cote GJ, Bugalho MM, Ordonez N, Evans DB, Goepfert H, Khorana S, Schultz P, Richards CS, Gagel RF) J Clin Endocrinol Metab 1996 Oct;81(10):3740-5 PMID 8855832
  • Association of gastric adenocarcinoma with the HLA class II gene DQB10301. (Lee JE, Lowy AM, Thompson WA, Lu M, Loflin PT, Skibber JM, Evans DB, Curley SA, Mansfield PF, Reveille JD) Gastroenterology 1996 Aug;111(2):426-32 PMID 8690208
  • The need for standardized pathologic staging of pancreaticoduodenectomy specimens. (Staley CA, Cleary KR, Abbruzzese JL, Lee JE, Ames FC, Fenoglio CJ, Evans DB) Pancreas 1996 May;12(4):373-80 PMID 8740405
  • Molecular diagnosis of exocrine pancreatic cancer using a percutaneous technique. (Evans DB, Frazier ML, Charnsangavej C, Katz RL, Larry L, Abbruzzese JL) Ann Surg Oncol 1996 May;3(3):241-6 PMID 8726178
  • Vascular involvement in pancreatic adenocarcinoma: reassessment by thin-section CT. (Loyer EM, David CL, Dubrow RA, Evans DB, Charnsangavej C) Abdom Imaging 1996 May-Jun;21(3):202-6 PMID 8661548
  • Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2. (Wohllk N, Cote GJ, Evans DB, Goepfert H, Ordonez NG, Gagel RF) Endocrinol Metab Clin North Am 1996 Mar;25(1):1-25 PMID 8907678
  • Pancreatic adenocarcinoma cell line, MDAPanc-28, with features of both acinar and ductal cells. (Frazier ML, Fernández E, de Llorens R, Brown NM, Pathak S, Cleary KR, Abbruzzese JL, Berry K, Olive M, Le Maistre A, Evans DB) Int J Pancreatol 1996 Feb;19(1):31-8 PMID 8656025
  • Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. (Fuhrman GM, Leach SD, Staley CA, Cusack JC, Charnsangavej C, Cleary KR, El-Naggar AK, Fenoglio CJ, Lee JE, Evans DB) Ann Surg 1996 Feb;223(2):154-62 PMID 8597509
  • Alternative method for exposure of the retropancreatic mesenteric vasculature during total pancreatectomy. (Leach SD, Davidson BS, Ames FC, Evans DB) J Surg Oncol 1996 Feb;61(2):163-5 PMID 8606551
  • Vascular resection and intraoperative radiation therapy during pancreaticoduodenectomy: rationale and technique. (Evans DB, Lee JE, Leach SD, Fuhrman GM, Cusack JC Jr, Rich TA) Adv Surg 1996;29:235-62 PMID 8720006
  • Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. (Staley CA, Lee JE, Cleary KR, Abbruzzese JL, Fenoglio CJ, Rich TA, Evans DB) Am J Surg 1996 Jan;171(1):118-24; discussion 124-5 PMID 8554125
  • Surgical management, DNA content, and patient survival in adrenal cortical carcinoma. (Lee JE, Berger DH, el-Naggar AK, Hickey RC, Vassilopoulou-Sellin R, Gagel RF, Burgess MA, Evans DB) Surgery 1995 Dec;118(6):1090-8 PMID 7491528
  • Preoperative chemoradiation for adenocarcinoma of the pancreas: excessive toxicity of prophylactic hepatic irradiation. (Evans DB, Abbruzzese JL, Cleary KR, Buchholz DJ, Fenoglio CJ, Collier C, Rich TA) Int J Radiat Oncol Biol Phys 1995 Nov 1;33(4):913-8 PMID 7591902
  • Clinical use of molecular information in the management of multiple endocrine neoplasia type 2A. (Gagel RF, Cote GJ, Martins Bugalho MJ, Boyd AE 3rd, Cummings T, Goepfert H, Evans DB, Cangir A, Khorana S, Schultz PN) J Intern Med 1995 Oct;238(4):333-41 PMID 7595169
  • Significance of peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreatic head. (Leach SD, Rose JA, Lowy AM, Lee JE, Charnsangavej C, Abbruzzese JL, Katz RL, Evans DB) Surgery 1995 Sep;118(3):472-8 PMID 7652681
  • Preoperative combined modality therapy for pancreatic cancer. (Rich TA, Evans DB) World J Surg 1995 Mar-Apr;19(2):264-9 PMID 7754633
  • Fine needle aspiration of the pancreas. In quest of accuracy. (Robins DB, Katz RL, Evans DB, Atkinson EN, Green L) Acta Cytol 1995 Jan-Feb;39(1):1-10 PMID 7846994
  • Indeterminate fine-needle aspiration biopsy of the thyroid: identification of subgroups at high risk for invasive carcinoma. (Tyler DS, Winchester DJ, Caraway NP, Hickey RC, Evans DB) Surgery 1994 Dec;116(6):1054-60 PMID 7985087
  • Resection for cure of carcinoma of the colon directly invading the duodenum or pancreatic head. (Curley SA, Evans DB, Ames FC) J Am Coll Surg 1994 Nov;179(5):587-92 PMID 7952464
  • Managing unsuspected tumor invasion of the superior mesenteric-portal venous confluence during pancreaticoduodenectomy. (Cusack JC Jr, Fuhrman GM, Lee JE, Evans DB) Am J Surg 1994 Oct;168(4):352-4 PMID 7943594
  • Adrenal medullary disease in multiple endocrine neoplasia type 2. Appropriate management. (Evans DB, Lee JE, Merrell RC, Hickey RC) Endocrinol Metab Clin North Am 1994 Mar;23(1):167-76 PMID 7913023
  • Reoperative pancreaticoduodenectomy. (Tyler DS, Evans DB) Ann Surg 1994 Feb;219(2):211-21 PMID 7907464
  • Fine-needle aspiration of pancreatic extramedullary plasmacytoma: possible confusion with islet cell tumor. (Dodd LG, Evans DB, Symmans F, Katz RL) Diagn Cytopathol 1994;10(4):371-4; discussion 374-5 PMID 7924813
  • Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. (Fuhrman GM, Charnsangavej C, Abbruzzese JL, Cleary KR, Martin RG, Fenoglio CJ, Evans DB) Am J Surg 1994 Jan;167(1):104-11; discussion 111-3 PMID 7906097
  • Adjuvant radiotherapy and chemotherapy for biliary and pancreatic cancer. (Rich TA, Evans DB, Curley SA, Ajani JA) Ann Oncol 1994;5 Suppl 3:75-80 PMID 8204533
  • Nonfunctioning islet cell carcinoma of the pancreas. (Evans DB, Skibber JM, Lee JE, Cleary KR, Ajani JA, Gagel RF, Sellin RV, Fenoglio CJ, Merrell RC, Hickey RC) Surgery 1993 Dec;114(6):1175-81; discussion 1181-2 PMID 7903005
  • Isolated splenic metastases from colon carcinoma. (Thomas SM, Fitzgerald JB, Pollock RE, Evans DB) Eur J Surg Oncol 1993 Oct;19(5):485-90 PMID 8405487
  • Extramedullary plasmacytoma of the pancreas. (Davidson BS, Lee JE, Dodd LG, Dimopoulos MA, Evans DB) Am J Clin Oncol 1993 Aug;16(4):363-8 PMID 8328417
  • Intraoperative radiation therapy following pancreaticoduodenectomy. (Evans DB, Termuhlen PM, Byrd DR, Ames FC, Ochran TG, Rich TA) Ann Surg 1993 Jul;218(1):54-60 PMID 8101073
  • Feeding jejunostomy techniques. (Ota DM, Evans DB) Surgery 1993 May;113(5):598 PMID 8488485
  • Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. (Evans DB, Rich TA, Byrd DR, Cleary KR, Connelly JH, Levin B, Charnsangavej C, Fenoglio CJ, Ames FC) Arch Surg 1992 Nov;127(11):1335-9 PMID 1359851
  • Laparoscopic feeding jejunostomy tube in oncology patients. (Ellis LM, Evans DB, Martin D, Ota DM) Surg Oncol 1992 Jun;1(3):245-9 PMID 1341257
  • Human cell line from an adenocarcinoma of the ampulla of Vater. (Frazier ML, Brown N, Pathak S, Mackay B, Cleary K, Olive M, Byrd DR, Evans DB, Levin B) In Vitro Cell Dev Biol 1992 Mar;28A(3 Pt 1):149-53 PMID 1582987
  • Use of Dexon Mesh for abdominal partitioning above the peritoneal reflection. (Evans DB, Shumate CR, Ames FC, Rich TA) Dis Colon Rectum 1991 Sep;34(9):833-5 PMID 1914752
  • Preoperative chemoradiotherapy for adenocarcinoma of the pancreas. Rationale and technique. (Evans DB, Byrd DR, Mansfield PF) Am J Clin Oncol 1991 Aug;14(4):359-64 PMID 1862769
  • Oncocytic adrenal cortical carcinoma. (el-Naggar AK, Evans DB, Mackay B) Ultrastruct Pathol 1991 Jul-Oct;15(4-5):549-56 PMID 1755111
  • Adenocarcinoma of the pancreas: current management of resectable and locally advanced disease. (Evans DB, Rich TA, Byrd DR, Ames FC) South Med J 1991 May;84(5):566-70 PMID 2035074
  • Grants and Awards

  • Pancreatic Cancer Research Program (#9520161 09/01/2009 - 08/31/2014) Sponsor: AHW-Research and Education Program